SPONSOR
O&D BioTech Group CO., Limited
Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Relapsed or Refractory Multiple Myeloma
O&D BioTech Group CO., Limited is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Relapsed or Refractory Multiple Myeloma.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — O&D BioTech Group CO., Limited
How many clinical trials has O&D BioTech Group CO., Limited sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by O&D BioTech Group CO., Limited, of which 1 are actively recruiting participants. These trials cover conditions including Relapsed or Refractory Multiple Myeloma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does O&D BioTech Group CO., Limited research focus on?
O&D BioTech Group CO., Limited clinical trials span Relapsed or Refractory Multiple Myeloma. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a O&D BioTech Group CO., Limited clinical trial?
To participate in a O&D BioTech Group CO., Limited trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all O&D BioTech Group CO., Limited trials with current recruitment status updated daily.
Clinical Trials by O&D BioTech Group CO., Limited
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology